Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07492849Completed

Prevalence of Sarcopenia in Stroke Patients

Role: lead

NCT06573567Not ApplicableCompleted

Bioimpedance Analysis for Hemodialysis

Role: lead

NCT05360667Not ApplicableCompleted

Using Exergame-based Program in Elders of Rural LTCF

Role: lead

NCT03809104Not ApplicableCompleted

VR-based Rehabilitation in the Treatment and Prevention of Sarcopenia of Older Residents

Role: lead

All 4 trials loaded